The antiviral COVID-19 pills developed by U.S. firms are the next step in the pandemic battle.
However, some countries have raised concerns that shortages and manufacturing chaos could hamper the global supply, according to The Washington Post.
Wealthy countries have already advance-purchased much of the supply of treatments expected to be available in the first half of 2022.
A great company to deal with, extremely reliable with a good range of products. Excellent product knowledge, great communication & customer service, fair prices and fast delivery.